Where I see patients (1)
Selected research
-
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.
Bone marrow transplantation
-
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Journal of the National Cancer Institute
-
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Journal of the National Cancer Institute